Jay Bhattacharya will have his work cut out for him if he wins confirmation as the next director of the U.S. NIH. Besides ...

Jazz Pharmaceuticals plc is buying Chimerix Inc. for $8.55 a share in cash, bringing the deal in at about $935 million. Jazz expands its cancer pipeline with the new acquisition’s lead candidate, ...

Ajax Health LLC, with backing from the $4 billion KKR Health Care Strategic Growth Fund II, and Boston Scientific Corp.

The U.K. has released a huge repository of children’s genomic data after sequencing blood samples from three large cohorts recruited at birth and followed across three decades. The power of the data ...

Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A ...

Researchers at the University of California San Diego have uncovered a key mechanism underlying the treatment resistance of ...

Dimicare Biotech and affiliated organizations have presented the discovery and preclinical characterization of DCB-001, a ...

Sofinnova Partners raised a whopping €1.2 billion (US$1.26 billion) over the past year to invest in life sciences companies ranging from incubation to later-stage growth, and spanning biotech, med ...

The executive orders (EOs) pouring out of the Trump White House, and the resulting court challenges, continue to pile up, deepening the uncertainty hanging over the life sciences sector and the U.S.

The U.S. Patent and Trademark Office has reversed a 2022 agency memorandum on discretionary denials of patent procedures, ...

Epigenetic editing is a promising method for gene regulation in vitro and in vivo, allowing precise control of gene ...

Avirmax Biopharma Inc. has begun IND-enabling studies of ABI-201, a gene therapy for dry age-related macular degeneration ...